Sort
30,917 grants matching “tumor microenvironment”
Breast Cancer Intravoxel-incoherent-motion MRI Multisite (BRIMM) Study - Resubmission - 1
$536,037Eric Edward Sigmund · New York University School Of Medicine · UH3 · FY2023 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$536,018Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Role of PI3Kgamma in Tumor Progression and Metastasis
$535,870Judith A. Varner · University Of California, San Diego · R01 · FY2025 · CA
Role of PI3Kgamma in Tumor Progression and Metastasis
$535,870Judith A. Varner · University Of California, San Diego · R01 · FY2023 · CA
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$535,816Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
$535,758Melissa B Davis · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy
$535,737Mathewos Tessema · Lovelace Biomedical & Environmental Research Institute · R01 · FY2017 · CA
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
$535,708Michael Karin · University Of California, San Diego · R01 · FY2024 · CA
The Impact of Obesity on Radiotherapy Anti-Tumor Effects
$535,687Arta Monir Monjazeb · University Of California At Davis · R01 · FY2025 · CA
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$535,638Wei R. Chen · University Of Oklahoma · R01 · FY2022 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2017 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2018 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2021 · CA
Genomics of Acute Myelogenous Leukemia (AML): Relapse and Resistance Factors
$535,495John F Dipersio · Washington University · P01 · FY2011 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis
$535,436Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Changing Contraceptive Patterns and Ovarian Cancer Risk
$535,417Kathryn L Terry · Brigham And Women'S Hospital · R01 · FY2023 · CA
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
$535,359Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2023 · CA
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
$535,359Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2022 · CA
EZH2 in cancer biology and novel inhibitors
$535,301Jun Qi · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis
$535,285Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Project 1: Multi-scale modeling of adaptive drug resistance in BRAF-mutant melanoma
$535,239Peter Karl Sorger · Harvard Medical School · U54 · FY2022 · CA
Systemic RNA Delivery to Tumors
$535,205Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2022 · CA